Czech Republic Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Kinvey Strategy eBook Kinvey answers 7 critical questions about creating your mobile strategy and technology policies. See our answers in this free eBook. From our sponsors

Czech Republic Pharmaceuticals and Healthcare Report Q4 2013 Oct 16th 2013, 00:00, by swapnil BMI View: The Czech healthcare system is facing severe challenges as it struggles to contain budget deficits. At the same time, demand for pharmaceuticals and healthcare is expected to continue its steady growth trajectory, putting pressure on the state and insurers to raise premiums or cut back on services. We believe that pharmaceutical spending will rebound over the short term once funding for the healthcare system is stabilised and the macroeconomic outlook improves in line with the eurozone recovery. Headline Expenditure Projections ? Pharmaceuticals: CZK79.60bn (US$4.07bn) in 2012 to CZK81.16bn (US$3.96bn) in 2013; 2.0% in local currency terms and -2.6% … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=120557. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/czech-republic-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions